Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-24Clinical Trial Update: XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC) [Phase 3]
Phase 3 trial comparing 4 months vs 6 months of XELOX chemotherapy in gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NC410 plus pembrolizumab in advanced/metastatic solid tumors with various MSI statuses; terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2026-07-30Clinical Trial Results: Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating a combination of oxaliplatin, Xeloda (capecitabine), and cetuximab for first-line treatment of metastatic or unrese…
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]
Clinical trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in advanced or metastatic gastric cancer after one prio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Results: Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer [Phase 2]
Phase 2 trial results evaluating pembrolizumab in combination with ramucirumab for metastatic gastric cancer have been completed and results…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer
This clinical trial update evaluates immediate and functional outcomes of different reconstruction methods after proximal gastrectomy for ga…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Safety and Efficacy of Leucine-Restricted Diet in Gastric Cancer [Phase 1]
A Phase 1 clinical trial is evaluating the safety and potential efficacy of a leucine-restricted diet in gastric cancer, currently enrolling…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies [Phase 1]
Phase 1 trial of AUR106 in relapsed advanced malignancies has been terminated; the document provides a status update on this study.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]
Phase 1b/2 trial of AUR103 calcium in HER2-positive advanced gastric cancer and gastroesophageal junction adenocarcinoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating cord blood-derived CAR-NK cells in gastric cancer and pancreatic adenocarcinoma has completed status and…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma [Phase 1, Phase 2]
This Roche umbrella Phase 1/2 trial evaluating multiple treatment combinations in gastric and gastroesophageal junction carcinoma was termin…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update indicates a Phase 1/2 study of BHB810 in advanced gastric and GEJ adenocarcinoma, with the trial currently not yet rec…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Safety and Efficacy of Trastuzumab BS
Pfizer's trastuzumab biosimilar (Trastuzumab BS) in gastric cancer has completed the trial. Results were posted on 2026-04-14, assessing saf…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT) [Phase 2]
Phase 2 perioperative trial evaluating Spartalizumab with the FLOT chemotherapy regimen for resectable gastric cancer; results were posted o…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: 18F-FDG PET/CT in Gastric Cancer
A clinical trial evaluating 18F-FDG PET/CT in gastric cancer has completed. The study was sponsored by Sohag University.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer
A clinical trial investigating molecular and epidemiological risk factors for gastric cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer [Phase 3]
A Phase 3 clinical trial evaluating Adebrelimab as perioperative therapy for locally advanced gastric or gastroesophageal junction cancer is…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Nutrition Intervention Trials in Linxian Follow-up Study
This update reports the completion of nutrition intervention trials within the Linxian follow-up study on esophageal and gastric cancer, spo…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Trial of Neoadjuvant Durvalumab Plus Docetaxel, Oxaliplatin, S-1 Followed by Surgery and Adjuvant Durvalumab Plus S-1 Chemotherapy in Potentially Resectable MMR Proficient Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial of neoadjuvant durvalumab plus docetaxel, oxaliplatin and S-1 followed by surgery, with adjuvant durvalumab plus S-1, in poten…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating sintilimab with bevacizumab and XELOX/SOX in initially unresectable AFP-positive gastric/GEJ adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC [Phase 2]
A Phase 2 trial evaluating trastuzumab in combination with capecitabine and cisplatin in patients with tissue HER2-negative but serum HER2-p…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…